| 1 |
35411376 | Antibody Response to SARS-CoV-2 mRNA Vaccines in Patients with Rheumatic Diseases in Japan: Interim Analysis of a Multicenter Cohort Study. | 2022 Apr 12 |
1 |
| 2 |
32687015 | Rapidly progressive glomerulonephritis after introduction of certolizumab pegol: a case report. | 2021 Jan |
1 |
| 3 |
31931832 | BDNF promotes activation of astrocytes and microglia contributing to neuroinflammation and mechanical allodynia in cyclophosphamide-induced cystitis. | 2020 Jan 13 |
2 |
| 4 |
31777548 | Effects of cyclophosphamide combined with prednisone on TNF-α expression in treatment of patients with interstitial lung disease. | 2019 Dec |
3 |
| 5 |
28463035 | Inhibition of NF-κB/TNF-α pathway may be involved in the protective effect of resveratrol against cyclophosphamide-induced multi-organ toxicity. | 2017 Aug |
1 |
| 6 |
26451304 | Blockade of TNF-α signaling benefits cancer therapy by suppressing effector regulatory T cell expansion. | 2015 Oct |
3 |
| 7 |
24485462 | Sensitizing protective tumor microenvironments to antibody-mediated therapy. | 2014 Jan 30 |
1 |
| 8 |
24981320 | Young male patient diagnosed with cutaneous polyarteritis nodosa successfully treated with etanercept. | 2014 Jul |
2 |
| 9 |
23143555 | Effect of cyclophosphamide on cytokines in patients with primary Sjögren's syndrome-associated interstitial lung disease in South China. | 2013 Jun |
3 |
| 10 |
23359007 | Young male patient diagnosed with cutaneous polyarteritis nodosa successfully treated with etanercept. | 2013 Jan 30 |
2 |
| 11 |
23703311 | Neurosarcoidosis. | 2013 Aug |
1 |
| 12 |
22690149 | Astaxanthin treatment reduced oxidative induced pro-inflammatory cytokines secretion in U937: SHP-1 as a novel biological target. | 2012 Apr |
1 |
| 13 |
20693809 | Addition of infliximab to standard therapy for ANCA-associated vasculitis. | 2011 |
1 |
| 14 |
21546064 | Resolution of Behçet's syndrome associated pulmonary arterial aneurysms with infliximab. | 2011 Dec |
1 |
| 15 |
22041773 | [The effect of cyclophosphamide on cytokines in patients with primary Sjögren's syndrome-associated interstitial lung disease]. | 2011 Jul |
3 |
| 16 |
19513730 | [Translational aspects on the role of B-cells in autoimmune diseases. "From bench to bedside" and "from bed to benchside"]. | 2009 Jul |
1 |
| 17 |
19694643 | Tumor necrosis factor-alpha-associated mechanisms affecting the embryonic response to cyclophosphamide. | 2009 Sep |
2 |
| 18 |
17206641 | Predictive value of mucosal TNF-alpha transcripts in steroid-refractory Crohn's disease patients receiving intensive immunosuppressive therapy. | 2007 Jan |
1 |
| 19 |
17874631 | [Cyclophosphamide in the therapy of rheumatoid arthritis and its complications]. | 2007 Jun |
1 |
| 20 |
16646004 | Solid malignancies among patients in the Wegener's Granulomatosis Etanercept Trial. | 2006 May |
1 |
| 21 |
17110316 | Malignancies and soluble tumor antigens in rheumatic diseases. | 2006 Nov |
1 |
| 22 |
15888259 | Effects of interferon beta, cyclophosphamide and azathioprine on cytokine profile in patients with multiple sclerosis. | 2005 Apr-Jun |
2 |
| 23 |
16291906 | Efficacy of TNF {alpha} blockade in cyclophosphamide resistant neuro-Behçet disease. | 2005 Dec |
1 |
| 24 |
14712306 | Altered expression of antiviral cytokine mRNAs associated with cyclophosphamide's enhancement of viral oncolysis. | 2004 Jan |
1 |
| 25 |
14968341 | Wegener's granulomatosis. | 2004 Feb |
1 |
| 26 |
15367711 | Chemoinducible gene therapy: a strategy to enhance doxorubicin antitumor activity. | 2004 Sep |
1 |
| 27 |
15648440 | Crescentic glomerulonephritis associated with myeloperoxidase-antineutrophil-cytoplasmic antibodies: first report on the efficacy of primary anti-TNF-alpha treatment. | 2004 |
2 |
| 28 |
11982607 | Elevated monocytic IL-12 and TNF-alpha production in Wegener's granulomatosis is normalized by cyclophosphamide and corticosteroid therapy. | 2002 Apr |
1 |
| 29 |
10385089 | Pretransplant chemotherapy reduces inflammatory cytokine production and acute graft-versus-host disease after allogeneic bone marrow transplantation. | 1999 Jun 15 |
2 |
| 30 |
7620183 | Modulation of acute graft-versus-host-disease after allogeneic bone marrow transplantation by tumor necrosis factor alpha (TNF alpha) release in the course of pretransplant conditioning: role of conditioning regimens and prophylactic application of a monoclonal antibody neutralizing human TNF alpha (MAK 195F). | 1995 Aug 1 |
1 |
| 31 |
1615753 | Antileukemic effects of recombinant human tumor necrosis factor alpha (rh-TNF alpha) with cyclophosphamide or methotrexate on leukemia L1210 and leukemia P388 in mice. | 1992 |
1 |
| 32 |
2688030 | Tumor necrosis factors. | 1989 |
1 |
| 33 |
2695567 | Interleukin-2 induced systemic toxicity: induction of mediators and immunopharmacologic intervention. | 1989 |
1 |
| 34 |
3500254 | Cyclophosphamide-induced alterations in human monocyte functions. | 1987 Dec |
1 |